ABCA1 (ATP-binding cassette transporter A1) is a member of the ABC transporter family that plays a critical role in cholesterol efflux and lipid homeostasis throughout the body, including the central nervous system[@vasiliou2009]. In the brain, ABCA1 is essential for the lipidation of [apolipoprotein E](/proteins/apoe) (ApoE) secreted by [astrocytes](/cell-types/astrocytes), a process critical for [amyloid-beta](/proteins/amyloid-beta) clearance and neuronal function[@koldamova2007].
ABCA1 (ATP-binding cassette transporter A1) is a member of the ABC transporter family that plays a critical role in cholesterol efflux and lipid homeostasis throughout the body, including the central nervous system[@vasiliou2009]. In the brain, ABCA1 is essential for the lipidation of [apolipoprotein E](/proteins/apoe) (ApoE) secreted by [astrocytes](/cell-types/astrocytes), a process critical for [amyloid-beta](/proteins/amyloid-beta) clearance and neuronal function[@koldamova2007].
ABCA1 is expressed in many tissues, including liver, macrophages, [microglia](/cell-types/microglia-neuroinflammation), astrocytes, and neurons. Its dysfunction has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and atherosclerosis[@wahrle2005]. The protein functions as a key regulator of reverse cholesterol transport and is essential for the formation of [high-density lipoprotein](/proteins/hdl-particle) (HDL) particles.
Structure
ABCA1 has the typical architecture of ABC transporters[@takahashi2006]:
Transmembrane Domains
Two transmembrane domains (TMDs): Each containing 6 transmembrane helices
Extracellular loops: Form the substrate entry portal for lipids
Intracellular loops: Connect TMDs and contain regulatory elements
Nucleotide-Binding Domains
Two nucleotide-binding domains (NBDs): Located at the cytoplasmic face
Walker A motif: Binds ATP phosphate groups
Walker B motif: Coordinates magnesium ion
ABC signature (C-loop): Contains the conserved LSGGQ motif
H-loop (switch region): Contains the catalytic histidine for ATP hydrolysis
Structural Features
N-terminal extracellular domain: Unique to the ABCA subfamily
Coupling helices: Connect TMDs to NBDs for conformational transmission
Dimerization: Forms functional homodimers in the plasma membrane
Comparison with Other ABC Transporters
ABCA1 shares structural homology with other ABCA family members:
ABCA4: Retinal transporter (visual cycle)
ABCA2: Brain-expressed, associated with AD risk
ABCA3: Lung surfactant homeostasis
ABCA7: Cholesterol efflux, linked to AD
Normal Function
Cholesterol Efflux
ABCA1 is the central mediator of cellular cholesterol efflux[@yvan-charvet2010]:
Transfers cholesterol and phospholipids to apolipoproteins (ApoA-I, ApoE)
Mediates the first step in reverse cholesterol transport
Prevents foam cell formation in atherosclerosis
HDL Particle Formation
ABCA1 is essential for nascent HDL particle formation:
Liver X receptor (LXR) agonists are potent ABCA1 inducers[@zelcer2006]:
TO901317: Increases ABCA1 expression in vitro and in vivo
GW3965: Synthetic LXR agonist
Clinical challenge: Peripheral side effects (lipogenesis)
Clinical Trial Results
LXR agonists showed promise in AD mouse models[@fitz2010]
Limited by increased triglyceride levels
CNS-selective compounds in development
Gene Therapy
AAV-mediated ABCA1 delivery to CNS
Targeted expression in astrocytes
Potential for sustainable therapeutic benefit
Small Molecule Activators
Direct ABCA1 activators in development
Structure-activity relationship studies
Selective CNS-active compounds
Combination Approaches
LXR agonists with other therapeutics
ABCA1 upregulation plus Aβ immunotherapy
ApoE-directed therapies
Key Publications
[Takahashi K, et al., Purification and ATPase activity of human ABCA1 (2006)](https://pubmed.ncbi.nlm.nih.gov/16484230/)
[Volpicella M, et al., ATP-binding cassette transporters in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/31873872/)
[Vasiliou V, et al., Human ATP-binding cassette (ABC) transporter family (2009)](https://pubmed.ncbi.nlm.nih.gov/19515417/)
[Koldamova R, Lefterov I, Role of ABCA1 and ABCG1 transporters in cholesterol efflux and Alzheimer's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17430242/)
[Wahrle SE, et al., ABCA1 is required for normal central nervous system ApoE levels (2005)](https://pubmed.ncbi.nlm.nih.gov/15983038/)
[Zelcer N, Tontonoz P, Liver X receptors as integrators of metabolic and inflammatory signaling (2006)](https://pubmed.ncbi.nlm.nih.gov/16511593/)
[Fitz NF, et al., Liver X receptor agonist treatment ameliorates amyloid pathology (2010)](https://pubmed.ncbi.nlm.nih.gov/21045124/)
[Hu Y, et al., ABCA1 deficiency promotes amyloid pathology in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32717471/)
[Vitali C, et al., ABCA1 and cholesterol efflux in the brain (2014)](https://pubmed.ncbi.nlm.nih.gov/24854264/)
[Yvan-Charvet L, et al., ABCA1, ABCG1, and cholesterol homeostasis in macrophages (2010)](https://pubmed.ncbi.nlm.nih.gov/20167679/)
[Karinasinska JM, et al., ABCA1 deficiency and apoE metabolism in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23418355/)
[Pincher A, et al., ABCA1 in microglia and neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32848178/)
[Liu Q, et al., ABCA1 and Alzheimer's disease: mechanisms and therapeutic potential (2019)](https://pubmed.ncbi.nlm.nih.gov/31372849/)
[Chen J, et al., ABCA1 and cholesterol efflux in neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/28762176/)
[Microglia](/cell-types/microglia-neuroinflammation) - Cell type
References
[Takahashi K, Kimura Y, Kioka N, et al, Purification and ATPase activity of human ABCA1 (2006)](https://pubmed.ncbi.nlm.nih.gov/16484230/)
[Volpicella M, Leoni C, Fanizza I, et al, ATP-binding cassette transporters in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/31873872/)
[Vasiliou V, Vasiliou K, Nebert DW, Human ATP-binding cassette (ABC) transporter family (2009)](https://pubmed.ncbi.nlm.nih.gov/19515417/)
[Koldamova R, Lefterov I, Role of ABCA1 and ABCG1 transporters in cholesterol efflux and Alzheimer's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17430242/)
[Wahrle SE, Jiang H, Parsadanian M, et al, ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted ApoE (2005)](https://pubmed.ncbi.nlm.nih.gov/15983038/)
[Zelcer N, Tontonoz P, Liver X receptors as integrators of metabolic and inflammatory signaling (2006)](https://pubmed.ncbi.nlm.nih.gov/16511593/)
[Fitz NF, Cronican A, Pham T, et al, Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits (2010)](https://pubmed.ncbi.nlm.nih.gov/21045124/)
[Hu Y, Meuret C, Go C, et al, ATP-binding cassette transporter A1 deficiency promotes amyloid pathology in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32717471/)
[Vitali C, Wellington C, Calabrese V, ABCA1 and cholesterol efflux in the brain (2014)](https://pubmed.ncbi.nlm.nih.gov/24854264/)
[Yvan-Charvet L, Wang N, Tall AR, ABCA1, ABCG1, and cholesterol homeostasis in macrophages (2010)](https://pubmed.ncbi.nlm.nih.gov/20167679/)
[Karasinska JM, et al, ABCA1 deficiency and apoE metabolism in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23418355/)
[Pincher A, et al, ABCA1 in microglia and neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32848178/)
[Liu Q, et al, ABCA1 and Alzheimer's disease: mechanisms and therapeutic potential (2019)](https://pubmed.ncbi.nlm.nih.gov/31372849/)
[Chen J, et al, ABCA1 and cholesterol efflux in neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/28762176/)